Seikagaku Pandemic Recovery Complicated by JOYCLU Side Effects

Seikagaku's logo

Seikagaku reported FY 1Q21 orthopedic revenue of USD $33.3 million, +14.4% vs. FY 1Q20. Marketshare gains in the U.S. and China drove the growth, while domestic sales in Japan decreased due to pricing reductions and ordering patterns.

In June 2021, Seikagaku issued a Dear Healthcare Professionals Letter of Rapid Safety Communication (Blue...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us